Skip to main content

Table 3 Perceived effectiveness of domperidone use according to maternal and infant characteristics, rated on a Likert scale of 1 (not at all effective) to 5 (extremely effective)

From: Women’s experiences with using domperidone as a galactagogue to increase breast milk supply: an Australian cross-sectional survey

 

n (%)

Mean ± SD

P—value

Infants age at survey

  

0.882*

  < 6 months

110 (31)

3.2 ± 1.3

 

  > 6 – ≤ 12 months

79 (20)

3.4 ± 1.2

 

  ≥ 12 months

163 (46)

3.3 ± 1.2

 

Education level

  

0.711#

 Completed secondary school

324 (92)

3.3 ± 1.2

 

 Did not complete school

31 (8)

3.3 ± 1.1

 

Parity

  

0.943#

 Primiparous

205 (58)

3.3 ± 1.2

 

 Multiparous

150 (42)

3.3 ± 1.2

 

Plurality

  

0.794#

 Multiple birth

9 (3)

3.2 ± 1.0

 

 Singleton

346 (97)

3.3 ± 1.2

 

Gestation at birth

  

0.934#

 Preterm

74 (21)

3.3 ± 1.2

 

 Term

281 (79)

3.3 ± 1.2

 

Method of delivery

  

0.428#

 C-section

162 (46)

3.3 ± 1.2

 

 Vaginal

193 (54)

3.4 ± 1.2

 

Self-perceived breast milk supply

  

0.512#

 Perceived low supply

327 (92)

3.3 ± 1.2

 

 No supply issue

28 (8)

3.5 ± 1.0

 

Lactation support

  

0.517#

 Saw a lactation consultant

311 (88)

3.3 ± 1.2

 

 Did not see a lactation consultant

44 (12)

3.4 ± 1.3

 

Additional feeding requirements

  

0.001#

 Required infant formula

251 (71)

3.2 ± 1.2

 

 Did not require infant formula

104 (29)

3.6 ± 1.1

 

Dose used

  

0.310*

  ≤ 30 mg/day

178 (50)

3.3 ± 1.2

 

 31 – 60 mg/day

155 (44)

3.2 ± 1.2

 

  ≥ 61 mg/day

22 (6)

4.2 ± 0.9

 

Start period

  

0.412*

  < 7 days

67 (19)

3.0 ± 1.3

 

 1 – 4 Weeks

134 (38)

3.3 ± 1.2

 

  > 4 Weeks

154 (43)

3.5 ± 1.1

 
  1. * One-way ANOVA
  2. # Student's T-test